HELIOS Kliniken

Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. (2024) Massa C, Karn T, Weber KE, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al. Journal article, Letter [Not Available]. (2024) Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, et al. Journal article Simultaneous Detection and Conversion Among Endoscopic Enhancement Modalities (2024) Chaudhari U, Kolawole BB, Santacroce G, Zanmarchi I, Del Amor R, Meseguer P, Buda A, et al. Conference contribution Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany (2024) Friedrich R, Kernder A, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, et al. Journal article Offene Chirurgie der aortoiliakalen Strombahn zur Behandlung der PAVK (2024) Rother U, Meyer A Journal article Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery (2024) Moustakis C, Blanck O, Grohmann M, Albers D, Bartels D, Bathen B, Borzì GR, et al. Journal article Transoral laser microsurgery for supraglottic carcinomas: results of a prospective multicenter trial (SUPRATOL) (2024) Ambrosch P, Meuret S, Dietz A, Fazel A, Fietkau R, Tostmann R, Schroeder U, et al. Journal article Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study) (2024) Passoke S, Stern C, Häußler V, Kümpfel T, Havla J, Engels D, Jarius S, et al. Journal article Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort (2024) Tscharntke LT, Jung N, Hanses F, Koll CE, Pilgram L, Rieg S, Borgmann S, et al. Journal article Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens. (2024) Baden D, Zukunft S, Hernandez G, Wolgast N, Steinhauser S, Pohlmann A, Schliemann C, et al. Journal article